Multiple myeloma is a progressive blood disease. It is a cancer of the plasma cell, an important cell in the immune system that produces antibodies for fighting infection. It is currently considered incurable, but it is treatable. There are several promising new therapies that are helping patients live longer, healthier lives. In Colorado, the cumulative lifetime risk of blood cancer is one in 107 for males and one in 164 for females. Five-year survival is about 35%. Incidence and mortality rates are higher for blacks.
Multiple Myeloma 1
- Support ongoing research into development of screening tools for earlier detection.
Multiple Myeloma 2
- Support ongoing research into development of better treatment regimens.
Multiple Myeloma 3
- Create a clearing house for current clinical trials and increase patient participation in them.